Dermatofibrosarcoma Protuberans
A rare, slow-growing skin cancer that grows locally
Quick Facts
- Type: Rare soft-tissue skin cancer
- Growth: Slow, locally invasive
- Spread: Rarely spreads to other organs
- Main treatment: Surgical removal
Overview
Dermatofibrosarcoma protuberans, often shortened to DFSP, is a rare type of skin cancer that arises in the deeper (dermal) layer of the skin and the connective tissue beneath it. It grows slowly over months to years and is considered a low-grade cancer, meaning it rarely spreads to distant parts of the body.
However, DFSP is locally aggressive: it sends out thin, root-like extensions into surrounding tissue that reach beyond what is visible on the surface. This is why it can come back after removal if not treated thoroughly. It often appears first as a small, firm patch or bump on the skin, most commonly on the trunk, shoulders, or limbs. With appropriate surgery, the outlook is generally very good, but careful, complete removal is important.
Symptoms
DFSP usually develops slowly and may be mistaken for a harmless lump or scar in its early stages.
- A firm patch or bump on the skin, often skin-colored, reddish, or brownish
- A slowly enlarging area that may feel rubbery or hard
- An appearance that can resemble a scar, birthmark, or harmless growth
- Later, the formation of raised, protruding nodules (the "protuberans" part of the name)
- Occasionally tenderness, bleeding, or ulceration as it grows
Because it grows so slowly and looks unremarkable at first, DFSP is sometimes present for years before it is diagnosed. Any firm skin growth that slowly enlarges, changes, or recurs after removal should be checked by a doctor.
Causes
The exact reason DFSP develops is not fully known, but research has shown it is linked to a change in the genetic material of the affected cells. Key points include:
- A specific genetic change: Most DFSP tumors have a characteristic rearrangement of genes that drives uncontrolled growth of the connective-tissue cells. This change is not inherited and develops within the tumor cells themselves.
- Not clearly linked to sun exposure: Unlike many common skin cancers, DFSP is not strongly tied to ultraviolet light.
- Possible association with prior skin injury or scarring in some cases, though this is not a proven cause.
There is no known way to prevent DFSP, so early recognition and treatment are the focus.
Risk Factors
- Adulthood, as it most often appears in early to middle adult life
- Although rare overall, it can occur at any age, including occasionally in children
- Possible prior trauma or scarring at the site in some cases
- No strong link to family history or sun exposure
Diagnosis
Diagnosis requires examining a sample of the growth under a microscope, since DFSP can look like more common, harmless lesions.
- Skin biopsy: Removing part or all of the lesion for laboratory examination is the key step.
- Specialized tests: Laboratory studies can detect the characteristic genetic change that confirms DFSP.
- Imaging: MRI may be used for larger or deeper tumors to assess their extent before surgery.
An accurate diagnosis is important because DFSP is often confused with benign skin lumps, and getting it right ensures proper treatment.
Treatment
The main treatment is surgery to remove the tumor completely, including its hidden extensions into surrounding tissue.
- Wide surgical removal: Taking out the tumor along with a margin of normal-looking tissue to capture its root-like spread.
- Mohs surgery: A specialized technique that removes and examines tissue layer by layer to ensure clear margins while sparing healthy skin, often preferred for DFSP.
- Radiation therapy: Sometimes used after surgery if margins are uncertain or the tumor cannot be fully removed.
- Targeted medication: For the rare advanced or recurrent cases that cannot be controlled with surgery, a targeted drug aimed at the tumor's genetic change may be used.
- Long-term follow-up: Regular checks because DFSP can recur locally, sometimes years later.
With complete removal, the outlook is generally favorable, though ongoing monitoring is advised.
Prevention
- There is no known way to prevent DFSP, so early detection is most important
- Check your skin and note any firm patch or bump that slowly enlarges
- Have any growth that changes, bleeds, or returns after removal evaluated
- Attend all recommended follow-up visits after treatment
- Report any new lump at or near a previous DFSP site promptly
When to See a Doctor
See a doctor or dermatologist if you notice a firm skin patch or lump that is slowly growing, changing, or has come back after being removed, even if it seems harmless. Prompt evaluation and biopsy allow DFSP to be diagnosed and treated early, which gives the best chance of complete removal and reduces the risk of it returning.
Frequently Asked Questions
Is dermatofibrosarcoma protuberans a serious cancer?
DFSP is a low-grade cancer that grows slowly and rarely spreads to other organs, so the outlook is generally good. However, it grows into surrounding tissue and can come back if not completely removed, so thorough treatment and follow-up are important.
What does DFSP look like?
It often begins as a firm, slowly enlarging patch or bump that may be skin-colored, reddish, or brownish and can resemble a scar or harmless growth. Over time it may form raised, protruding nodules.
How is DFSP diagnosed?
A skin biopsy examined under a microscope is the key step, and specialized tests can detect the characteristic genetic change that confirms the diagnosis. Imaging such as MRI may be used for larger tumors.
How is dermatofibrosarcoma protuberans treated?
The main treatment is surgery to remove the tumor with a margin of healthy tissue, often using Mohs surgery to ensure complete removal. Radiation or a targeted medication may be used in certain advanced or recurrent cases.
Can DFSP come back after treatment?
Yes, DFSP can recur locally, sometimes years later, because of its root-like spread into surrounding tissue. This is why complete surgical removal and long-term follow-up are recommended.
References
- American Cancer Society. Soft tissue sarcoma.
- National Cancer Institute (NCI). Skin cancer treatment.
- DermNet. Dermatofibrosarcoma protuberans.
- MedlinePlus, U.S. National Library of Medicine. Soft tissue sarcoma.